Did you know?
ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.
Free Newsletter
Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!
Free Report
For better result, minimum character length is four(4)
Giant Pharma Seeks to Maintain Its Position in...
Biotech Runs Ahead of Broad Market. More details...
Aurora Kinase VX-680 Takes on Hematological Cancer. More...
CBT 200 Adds to Yesterday's Gain. More details...
Cancer Immunotherapy Company Ready for Clinic. More...
CBT 200 Shows Relative Strength. More details...
CBT 200 Down For Third Session in a Row. More details...
CBT 200 Gives Up 13 Points. More details...
65th Annual Meeting Showcases Impending Drugs. More...
CBT 200 Moves 8 Points Higher. More details...
ChinaBio® News
Greg Scott Interviewed at BIO-Europe Spring
How to bring your China assets to China in 8 minutes
"Mr. Bio in China."
Mendelspod Interview
Multinational pharma held to a higher standard in China
